Operating clinics, polyclinics, and specialty practices in Dubai (DHA), Abu Dhabi (DOH), and the Northern Emirates (MOHAP) typically transact at 0.6x to 1.5x of annual revenue, with stabilised multi-doctor groups commanding 4x to 6x EBITDA. Premium pricing is consistent with patient continuity, physician contracts, and verifiable insurance contract panels.
SHARH structures healthcare sales around two non-negotiables: confidential pre-marketing (most owners cannot afford even a whisper to leak to staff before a deal is signed) and DD support that covers the elements GP-style brokers miss — Tasneef classifications, malpractice insurance continuity, and HAAD/DHA license-transfer timelines.
Buyers ranging from regional consolidators to physician partnerships use the SHARH marketplace to access opportunities that never reach broker WhatsApp groups or open advertising. Every active healthcare listing has been screened for licence transferability and at least 24 months of operating financials.